Govt Job: For M.Pharm as Bench Chemist at CDSCO – Govt of India

The Central Drugs Standard Control Organization (CDSCO) is the Central Drug Authority for discharging functions assigned to the Central Government under the Drugs and Cosmetics Act.

CDSCO has six zonal offices, four sub-zonal offices, 13 port offices and seven laboratories under its control.

Post : Bench Chemist

The Central Drugs Testing Laboratory, Hyderabad is statutory laboratory working under the administrative control of Drugs Controller General (India), CDSCO, a subordinate office of the Directorate General of Health Services under the Ministry of Health & Family Welfare, has the vacancies against various outsourced positions as per details shown below.

No of Posts : 05

Remuneration (Rs.) : Rs.33600/-

Sanctioned up to : 31.03.2022

Qualification & Experience :
•  Post Graduate Degree in Pharmaceutical Sciences / Pharmaceutical chemistry from a recognized university with 60 % marks

• Candidates having knowledge of GLP/ ICH/ISO guidelines and experience in testing of drugs, cosmetics and medical devices as per Drugs Cosmetics Act will be given preference.

Job description
To perform analysis of Drugs, Cosmetics & Medical Devices in the laboratory for certifying their quality as per prescribed standards. Maintenance and calibration of various analytical instruments.

Maintenance of records as per Schedule L1. These duties will be carried out by the candidate under the supervision of Head of the Laboratory/Lab In-Charge.

He/she will be responsible for any other work/responsibilities assigned by the Head of Laboratory/ Lab In- Charge from time to time.

Receipt of application & Shortlisting for written test / Interview
a. In case, number of applications are high, suitable shortlisting criteria of candidates will be done with preference for candidates having desirable qualification and experience.

b. Written test or Interaction shall be communicated to shortlisted candidates.

The selected candidates will receive the appointment order from outsourcing agency.

1) The last date for applications is on or before 18.02.2022 by 5.30 p m along with the enclosures.

2) Application are not accepted directly as hard copy / by post / after due date will not be entertained.

Related Posts

WHO launches new primary health care course to strengthen health systems globally

Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

WHO launches new primary health care course to strengthen health systems globally

WHO launches new primary health care course to strengthen health systems globally

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert